For example, diazenylaryl sulfonic acid has shown significant potential by simultaneously reducing viral replication and bacterial adhesion during co-infections, while pyrrolo[2,3-e]indazole effectively targets viral NA (H1N1 and H3N2 strains) and pneumococcal NA (NanA). This evidence concerns the gene XK and coinfection.